(Total Views: 197)
Posted On: 07/22/2019 4:41:13 PM
Post# of 145254
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
We need approval for Leronlimab for combo, off-label usage will quickly become normal and popular. CYDY is not allowed to advertise off-label drug use but HIV-1 population will quickly accept something better. Some companies do not go into additional trials for finance but already count on off-label. Leronlimab becomes the Gilead competition as soon as it is approved as a combo.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)